The U.S. Food and Drug Administration (FDA) has approved the
enVista hydrophobic acrylic intraocular lens (IOL), announced Bausch + Lomb. The lens is the
first and only FDA-approved IOL in the U.S. with labeling that states:
"No glistenings of any grade were reported for any subject at any visit
in the clinical study," notes B+ L. Glistenings
are fluid-filled microvacuoles that can form within an IOL and are
common in some hydrophobic acrylic IOLs. Glistenings may not only present an aesthetic issuebut could impact visual function, including visual
acuity and contrast sensitivity in patients, because a portion of light
coming into the eye could be scattered.
Read more.
No comments:
Post a Comment